title: HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer.
authors.affiliation: Department of Pathology, University of Utah, Salt Lake City.
authors.forename: H Evin
authors.initials: HE
authors.lastname: Gulbahce
authors.affiliation: Department of Pathology, University of Utah, Salt Lake City.
authors.forename: Rachel
authors.initials: R
authors.lastname: Factor
authors.affiliation: Department of Pathology, University of Utah, Salt Lake City.
authors.forename: Katherine
authors.initials: K
authors.lastname: Geiersbach
authors.affiliation: Department of Pathology, University of Utah, Salt Lake City.
authors.forename: Erinn
authors.initials: E
authors.lastname: Downs-Kelly
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism; D005260:Female; D018740:Genetic Heterogeneity; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods*; D017404:In Situ Hybridization, Fluorescence / Q000379:methods*; D010338:Pathology, Clinical / Q000379:methods; D017410:Practice Guidelines as Topic; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases